These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 27693678

  • 21. The Dynamic Intestinal Absorption Model (Diamod®), an in vitro tool to study the interconnected kinetics of gastrointestinal solubility, supersaturation, precipitation, and intestinal permeation processes of oral drugs.
    Moens F, Vandevijver G, De Blaiser A, Larsson A, Spreafico F, Augustijns P, Marzorati M.
    Int J Pharm X; 2023 Dec; 5():100177. PubMed ID: 37396621
    [Abstract] [Full Text] [Related]

  • 22. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
    Berlin M, Ruff A, Kesisoglou F, Xu W, Wang MH, Dressman JB.
    Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
    [Abstract] [Full Text] [Related]

  • 23. Gastric and Duodenal Ethanol Concentrations after Intake of Alcoholic Beverages in Postprandial Conditions.
    Rubbens J, Riethorst D, Brouwers J, Wolfs K, Adams E, Tack J, Augustijns P.
    Mol Pharm; 2017 Dec 04; 14(12):4202-4208. PubMed ID: 28731350
    [Abstract] [Full Text] [Related]

  • 24. The Effect of Food on the Intraluminal Behavior of Abiraterone Acetate in Man.
    Geboers S, Stappaerts J, Mols R, Snoeys J, Tack J, Annaert P, Augustijns P.
    J Pharm Sci; 2016 Sep 04; 105(9):2974-2981. PubMed ID: 27061460
    [Abstract] [Full Text] [Related]

  • 25. Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.
    Litou C, Vertzoni M, Goumas C, Vasdekis V, Xu W, Kesisoglou F, Reppas C.
    Pharm Res; 2016 Jun 04; 33(6):1399-412. PubMed ID: 26975361
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH.
    Br J Clin Pharmacol; 2002 Jun 04; 53(6):582-8. PubMed ID: 12047482
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gastrointestinal behavior of itraconazole in humans - Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution.
    Brouwers J, Geboers S, Mols R, Tack J, Augustijns P.
    Int J Pharm; 2017 Jun 15; 525(1):211-217. PubMed ID: 28414135
    [Abstract] [Full Text] [Related]

  • 33. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox®.
    Berben P, Stappaerts J, Vink MJA, Domínguez-Vega E, Somsen GW, Brouwers J, Augustijns P.
    Eur J Pharm Biopharm; 2018 Nov 15; 132():231-236. PubMed ID: 29959034
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.